BIND Therapeutics
Latest round
- Series D
Last raised
- Jan 2013
Total raised
- $76M
Investors
- 7
About BIND Therapeutics
Founded in 2006 and based in Cambridge, Massachusetts, BIND Therapeuticw, Inc. operates as a biopharmaceutical company that focuses on developing therapeutic targeted nanoparticles for the treatment of cancer, inflammatory, infectious, and cardiovascular diseases.
Who invested in BIND Therapeutics
7 investors across 7 rounds
See all investors in BIND Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Jan 23, 2013
Amount
$8.7M
Investors
Series D
Nov 22, 2011
Amount
$26M
Investors
Series C
Jun 11, 2010
Amount
$12M
Investors
Series C
Jan 11, 2010
Amount
$11M
Investors
Series B
Nov 14, 2007
Amount
$16M
Investors
Series A
Jan 29, 2007
Amount
$1M
Investors
Series A
Dec 13, 2006
Amount
$1.5M
Investors
Questions about BIND Therapeutics
Who invested in BIND Therapeutics?
BIND Therapeutics has 7 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BIND Therapeutics raised?
BIND Therapeutics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did BIND Therapeutics last raise money?
BIND Therapeutics's most recent round on record is a Series D, in Jan 2013.
What does BIND Therapeutics do?
Founded in 2006 and based in Cambridge, Massachusetts, BIND Therapeuticw, Inc.
Where is BIND Therapeutics headquartered?
BIND Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like BIND Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at BIND Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like BIND Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.